Trauma Handbook 2007
Transcript of Trauma Handbook 2007
-
8/8/2019 Trauma Handbook 2007
1/60
1
TRAUMA
RESIDENTHANDBOOK
Elvis Presley Memorial Trauma Center Department of Surgery
Division of Trauma and Surgical Critical CareUniversity of Tennessee Health Science Center
Memphis, Tennessee
-
8/8/2019 Trauma Handbook 2007
2/60
2
These policies are intended to serve as
guidelines only. Individualcircumstances must be considered, and
there may be times when it is
appropriate or desirable to deviate from
these guidelines. They should not be
considered to be accepted protocol or
policy, nor are they intended to replace
clinical judgment or to dictate care of individual patients. These educational
guidelines will be reviewed and updated
routinely.
-
8/8/2019 Trauma Handbook 2007
3/60
3
ContentsGENERAL P OLICIES
Trauma Service Policies 4Conferences and Clinics 10Service Assignments and Transfer 11Universal Precautions in the Trauma Rooms 12Criteria for Triage to Trauma Rooms 13Routine Trauma Labs 14Consults 15
HEAD /S PINE Cervical Spine Clearance 16Spinal Cord Injury with Deficit 17Dermatomes 18Sensory Levels 19Classification of Spinal Cord Injury 20
NECK Blunt Cerebrovascular Injury 22Penetrating Neck Injuries 23
CHEST Blunt Aortic Injury 24Emergent Thoracotomy 25Hemothorax 26
ABDOMEN /P ELVIS Hemodynamically Unstable Blunt Abdominal Trauma 27Hemodynamically Stable Blunt Abdominal Trauma 28Antibiotics for Penetrating Abdominal Trauma 29Anterior Abdominal Stab Wounds 30Blunt Liver Injury 31Blunt Splenic Injury 32Pancreatic Injury 33Organ Injury Scales 34Management of Pelvic Fractures 37Tile Classification of Pelvic Fractures 38
VASCULAR Ligate vs. Repair 39Neurovascular Injuries 40
EXTREMITIES Fracture/Dislocations 41Muscles and Nerves 42Mangled Extremity Severity Score 43
S URGICAL CRITICAL CARE Diagnosis & Empiric Therapy of VAP 44Risk Factors & Prophylaxis for DVT 47Herbal Supplements 48Ventilator Weaning 52Management of Hypertension 53Pharmacologic Agents 54Alcohol Withdrawal 55Sedation 56Stress Ulcer Prophylaxis 58ICP Management 59
-
8/8/2019 Trauma Handbook 2007
4/60
4
Trauma Service Policies
Welcome to the Trauma Service. To ensure optimal patient care as well as a
productive educational experience, the following guidelines have been formulated by
the Trauma staff. These policies cover the roles and goals for each resident and
medical student rotating on the Service, the responsibilities of each member of the
Trauma Team, specific policies regarding patient care, and other issues essential to
the efficient running of the Trauma Service.
General Policies
1. A complete and accurate trauma history and physical is required for all trauma
admissions. There are no exceptions.
2. A complete daily Trauma Service note in SOAP format addressing all problems
and containing all laboratories and other studies obtained is required on each
patient on the Trauma Service.
3. The trauma team is expected to respond to all Shock/Trauma room admissions.
Dismissal from the trauma room is at the discretion of the senior trauma resident.
-
8/8/2019 Trauma Handbook 2007
5/60
5
Resident/Medical Student Roles
The PGY-5 on the Trauma Service is the chief resident of the Trauma Service. This
resident is responsible for the Trauma Service. This includes running daily work
rounds and the Trauma Clinic. Morning rounds will include a review of the previous
nights work-ups to include radiology studies. This resident is responsible for the
coordination of care with consulting services. In order to comply with the work hour
restrictions, all residents are excused after turnover rounds following their night on
call.
Aside from the PGY-5 Trauma Resident, there is also a PGY-3/4 Trauma Resident, a
PGY-2 Trauma Resident, two PGY-1 Trauma Residents, and rotating medical
students. There are also two Surgical Critical Care fellows and at least one NursePractitioner. The daily responsibilities of the resident are as follows:
PGY-5 Trauma Resident
1. Initial response to all patients triaged to the Shock/Trauma Room.
2. Management of resuscitation in the Shock/Trauma Room.
3. Daily management of trauma patients.
4. Primary operative responsibility for trauma patients.5. Overseeing junior residents daily activities.
6. Detailed turnover rounds to the other chiefs when they assume call.
7. Trauma Conference coordination.
PGY-3/4 Trauma Resident
1. Daily management of TICU patients.
2. Assisting with resuscitation in the Shock/Trauma Room.
3. Detailed turnover rounds to the other TICU residents when they assume call.
4. Performing bedside procedures on TICU patients in conjunction with the Trauma
attending and/or fellow.
PGY-2 Trauma Resident
1. Management of patients in CCA.
-
8/8/2019 Trauma Handbook 2007
6/60
6
2. Assisting with resuscitation in the Shock/Trauma Room.
3. Emergency room consultations .
PGY-1 Trauma Residents
1. Management of patients on the 4 th floor ICUs in conjunction with the fellow and the
Nurse Practioner.
2. Assisting in Shock/Trauma Room resuscitations and recording the history and physical
exam.
3. Management of patients on the floors in conjunction with the chief.
4. Coordination of discharge planning with the case managers.
Medical Students Daily Responsibilities
1. Assisting in care of Shock/Trauma Room patients as dictated by the chief, fellow, and
attending.2. Assisting in care in CCA as dictated by the CCA Resident.
Surgical Critical Care fellows
1. Assist with management of Shock/Trauma patients.
2. Assist the operating surgeon (if appropriate).
3. Assist the ICU residents in critical care management.
4. Assist the Nurse Practitioner with management of Trauma Step-down patients.5. Assist the CCA resident as appropriate.
6. Serve as continuity liason between Trauma service and attendings.
Nurse Practitioners
1. Management of CCA patients in conjunction with the CCA resident.
2. Management of Trauma Step-down patients in conjunction with the fellow.
3. Assist the floor resident with patient management and discharge planning.
-
8/8/2019 Trauma Handbook 2007
7/60
7
Rotation Goals
PGY-11. Learn initial management of trauma patients to include ATLS.
2. Learn resuscitation techniques, goals and end points.
3. Use appropriate diagnostic modalities commonly employed in the evaluation of trauma
patients.
4. Become proficient in various procedures to include diagnostic peritoneal lavage, closed-
tube thoracostomy, central line placement, placement of pulmonary artery catheter and
interpretation of the values, tracheostomy, and feeding tube placement.
5. Learn post-injury patient care and facilitate timely and appropriate patient discharge.
6. Learn the basics of surgical critical care in conjunction with the fellow and attending.
PGY-21. Learn initial management and resuscitation of major trauma patients in conjunction with
the Chief Trauma Resident.
2. Assist in surgical intervention in trauma patients.
3. Learn how to evaluate surgical patients in the ER.
PGY-3/41. Obtain proficiency in evaluation and management of all trauma patients.
2. Become proficient in various procedures to include bedside fiberoptic bronchoscopy,bronchoalveolar lavage, arterial cannulation.
3. Become proficient in operative management of patients with significant trauma.
4. Become proficient in the care of critically injured ICU patients.
5. Become proficient with various vasoactive agents in management of critically injured
patients.
PGY-5
1. Obtain proficiency in evaluation and management (including operative management) of all trauma patients.
2. Assume the leadership role on the Trauma Service.
-
8/8/2019 Trauma Handbook 2007
8/60
8
Surgical Critical Care fellows
1. Develop proficiency in the diagnosis and management of critically ill patients, to include
appropriate interventions and procedures.
2. Create, design, implement, and analyze research projects.
3. Expand and develop the ability to teach associates, residents in training, and other
critical care personnel.
4. Learn to administer and manage a critical care unit with particular emphasis on
allocation and utilization or resources and on ethical principles in the delivery of healthcare.
-
8/8/2019 Trauma Handbook 2007
9/60
9
Rounding Schedule For 2005-2006
Main Call Attending
Responsible for daily rounds and procedures in the TICU, GICU, and
Shock/Trauma admissions
Second Call Attending
Responsible for daily rounds and procedures on the floor, Trauma Step-down,
and patients in CCA. This attending will also staff the Trauma Clinic on
Tuesday and Thursday.
Teaching Rounds
Tuesdays at 8:00 a.m. All members of the Trauma Service (fellows, residents
and students) are expected to attend.
-
8/8/2019 Trauma Handbook 2007
10/60
10
Conferences and Clinics
The Trauma Service is expected to attend these and all other applicable general surgical
conferences:
Attending Teaching Rounds* ALL Trauma team members are expected to be present *
Tuesday, 8:00 a.m., TICU
Trauma ConferenceThursday, 7:30 a.m.
Radiology Conference Room
2 nd Floor Chandler
Week 1: Trauma/Critical Care
Week 2: Orthopedics
Week 3: Neurosurgery (Ground floor Adams)
Week 4: Trauma M & M (fellows responsible for case selection)
Week 5: Case presentations
Trauma Clinic (4 th floor MedPlex)
Tuesday, 9:00 a.m. 12:00 p.m.
Thursday, 9:00 a.m. 12:00 p.m.
-
8/8/2019 Trauma Handbook 2007
11/60
11
Service Assignments and Interservice Transfer Guidelines
To facilitate patient care and to eliminate potential misunderstandings between various
services caring for trauma patients, the following guidelines have been established
regarding admission to and transfer of trauma patients between services.
1. Patients with multiple system injuries or hemodynamic instability will be admitted to theTrauma Service.
2. Patients with unisystem injury without a mechanism for potential multiple system injuries
may be admitted to the pertinent service if both attendings (Trauma and other service)
agree, and the Trauma Service may be consulted to provide the Critical Care services. In
general, patients may be admitted to the Trauma service for a 24 hour observation period
prior to transfer.
3. Patients with unisystem injuries with a mechanism for potential multiple system injuries
will be admitted to the Trauma Service if evaluation for occult injuries is ongoing. Reasons
to remain on the Trauma Service with unisystem injuries include hemodynamic or
respiratory instability, or occult injuries still in the process of being ruled out.
4. Patients with unisystem injury may be transferred to another service when the following
general criteria are met:
a. they are tolerating a diet and having bowel function;
b. they no longer need central venous access*;
c. they no longer require a Foley catheter*;
d. they are deemed ready by the Trauma attending and the other service.
Once a patient is transferred from the Trauma Service to another service, Trauma Service
followup will continue for at least three days post-transfer. Results of these visits will be
documented in the patient's medical record. exceptions may be made after agreement with all services
-
8/8/2019 Trauma Handbook 2007
12/60
12
Universal Precautions in the Trauma Rooms
All physicians, nurses, employees, students, and observers are required to wear all of
the following with all patients in trauma rooms:
1. Gloves
2. Gowns for procedures
3. Masks
4. Eye Coverings
5. Head covers
Non-compliance with Universal Precautions may result in disciplinary action. OSHA
standards require compliance.
The patients privacy will be respected under all circumstances. Therefore,
identifiable pictures and cell phone pictures are NOT allowed. However, pictures taken for
medical reasons are allowed.
-
8/8/2019 Trauma Handbook 2007
13/60
13
Criteria for Triage to Shock / Trauma Room
Physiological Alterations Trauma Score 13 Known GCS
-
8/8/2019 Trauma Handbook 2007
14/60
14
Routine Trauma Labs: Adult
The following laboratory tests should be ordered for all adult surgical trauma patients evaluated
in the trauma rooms:
CBC with differential Trauma BMP (to include total bilirubin, ALT, AST) P-amylase INR Lactate Arterial blood gas UA -- also UCG in female patients
Type and screen. Type and crossmatch only for any patient who receivesuncrossmatched blood (red tag) for resuscitation in Shock/Trauma, or any patient going
directly to the OR from Shock/Trauma.
-
8/8/2019 Trauma Handbook 2007
15/60
15
Plastic and Reconstructive surgery Oral and Maxillofacial surgery Otolaryngology
Plastic and Reconstructive surgery Orthopedic surgery
Orthopedic surgery (patients admitted on odd days) Neurosurgery (patients admitted on even days)
Obstetrics preferably notify prior to arrival
Consults
Facial fractures
Alternates weekly
Hand injuriesAlternates weekly
Spine injuriesAlternates daily
Pregnant patients
-
8/8/2019 Trauma Handbook 2007
16/60
16
Cervical Spine Clearance
Blunt neck trauma
Awake, alert, no distractinginjuries, asymptomatic,
NEUROLOGICALLY NORMAL
Altered mental status, ormultiple system injury, or
awake with cervical pain or tenderness, orclinical signs of spinal cord injury
No neck painAND
No tendernessto palpation
C-spine cleared(document on chart),
remove collar
AP, Lateral,Odontoid plain films
Adequate,normal films
Poorly visualized areaor abnormal
Leave collar on and consult Orthopedics (admission date an odd day)or Neurosurgery (admission date an even day) for evaluation
MRI of affectedarea
CT scan C-spine
Normal Abnormal
-
8/8/2019 Trauma Handbook 2007
17/60
17
Spinal Cord Injury with Neurologic Deficit
Penetrating Blunt
Bolus methylprednisolone(Solumedrol) 30 mg/kg over 15 min
(if within 8 hours from injury)
45 minute steroid free pause
Continuous infusion 5.4mg/kg/hr for 23-47 hours*23 hours if started 0-4 hours after injury47 hours if started 4-8 hours after injury
Obtain CT of affected area
Consultation:Orthopedics on odd admission date, Neurosurgery on even admission date
Strict log rollTake off backboard
Keep in cervical collar if cervicalinjury or altered sensorium
*In conjunctionwith Orthopedics/
Neurosurgery
Obtain MRI of affected area
-
8/8/2019 Trauma Handbook 2007
18/60
18
Dermatomes
-
8/8/2019 Trauma Handbook 2007
19/60
19
Sensory Levels
-
8/8/2019 Trauma Handbook 2007
20/60
20
Standard Neurological Classification of Spinal Cord InjuryMOTORKEY MUSCLES
R LC2C3
C4C5 Elbow flexorsC6 Wrist extensorsC7 Elbow extensorsC8 Finger flexors (distal phalanx of middle finger)T1 Finger abductors (little finger)T2T3 0 = total paralysisT4 1 = palpable or visible contraction T5 2 = active movement, T6 gravity eliminated T7 3 = active movement, T8 against gravity T9 4 = active movement,
T10 against some resistance T11 5 = active movement, T12 against full resistance L1 NT = Not testable L2 Hip flexorsL3 Knee extensors L4 Ankle dorsiflexorsL5 Long toe
extensorsS1 Ankle plantar
flexorsS2S3
S4-5 Voluntary anal contraction (Yes/No)
TOTALS + = MOTOR SCORE
maximum 50
50 100
NEUROLOGICAL R L COMPLETE OR INCOMPLETE?
LEVELS SENSORY Incomplete = Any sensory or motor functionin S4-S5
The most caudal MOTOR
segment with ASIA IMPAIRMENT SCALE
normal function
American Spinal Injury Association 1996
-
8/8/2019 Trauma Handbook 2007
21/60
21
SENSORY KEY SENSORY POINTS
LightTouch
PinPrick
R L R LC2 0 = absent C3 1 = impairedC4 2 = normalC5 NT = not testableC6C7C8T1T2T3T4T5T6T7T8T9T10T11T12L1L2L3L4L5S1S2S3S4-5 Any anal sensation (Yes/No)
+ = PIN PRICK SCORE Max: 112 TOTALS{
+ = LIGHT TOUCH SCORE Max: 112 Maximum 56 56 56 56
R L
SENSORY
MOTOR
ZONE OF PARTIALPRESERVATIONPartially innervated segments
-
8/8/2019 Trauma Handbook 2007
22/60
22
Blunt Cerebrovascular Injury
Appropriate mechanism with Unexplained neuro deficit (inconsistent with CT) Horners syndrome LeFort II or III (unilateral or bilateral) Cervical spine injury, including transverse process
fractures C-1 C-6 Neck soft tissue injury
4 vessel cerebral angiogram
Carotid injury Vertebral injury
Neurosurgeryconsult
Neurosurgeryconsult
Treatment** Treatment**
Heparin** if no contraindication(preferred for carotid & complexvertebral injuries)Start @ 1000 units/hour NO bolus
Aspirin Plavix**(ASA only if vertebral occludedwith back-fill)
Repeat angiogram in
14 days and/or 6weeks if necessary
Serial PTT, 1 st value 4hours after drip started
then q8hrsGoal is 1.5-2.0 x normal
**In conjunctionwith Neurosurgery
Conversion to Coumadin or antiplatelettherapy depending on pathology/clinicalcourse for at least 6 weeks, follow up inTrauma Clinic and with Neurosurgery
CT angiogram
-
8/8/2019 Trauma Handbook 2007
23/60
23
Penetrating Neck Injury
Hemodynamically unstableExpanding hematomaExcessive bleeding
Dysphonia*Dysphagia*Air leak from woundTracheal deviationRetropharyngeal air*
To OR
Platysma ViolationDO NOT PROBE WOUND!
Zone I Zone II Zone III
unstable stable unstable stable unstable stable
4 vessel cerebral angio, +/-arch angiogram, barium
swallow
Injury No Injury
TO OR Observe
To ORTo OR To OR
*May benefit fromdiagnostic test
such as plain lateralc-spine X-ray,barium swallow,bronchoscopy, or laryngoscopy
-
8/8/2019 Trauma Handbook 2007
24/60
24
Appropriate mechanism of injury includes high speed impact injuries (MVC, MCC, fall, decelerating bluntinjury).*BP & HR goals: systolic BP 120 mmHg, HR
-
8/8/2019 Trauma Handbook 2007
25/60
-
8/8/2019 Trauma Handbook 2007
26/60
26
Hemothorax Management
No
Place Chest Tube
Dail Chest X-Ra s
CT Chest
Clot ResolvedRemove Tube
Clot Resolved
Repeat CT Chest in 48 hours
1) Residual clot > 500cc OR2) Residual clot occupies >1/3 of thoracic cavity OR3) Unchanged
VATS Place SecondChest Tube
Yes
No
TPA Contraindications1) Active bleeding OR2) CVA in past 30 days OR3) Intracranial hemmorhage OR4) Intracranial Neoplasm OR5) Coagulopathy OR6) Pregnancy OR7) Chest tube with air leak
Repeat CT Chest
Repeat TPA infusion x 3 days(check daily chest x-ray)
TPA Infusion Protocol1) Obtain HCT, PT, PTT prior to infusion (if abnormal consider not using rTPA)2) Mix 4mg of rTPA (Reteplase ) in 50cc sterile saline.3) Instill mixture into chest tube and flush tube with 50cc of sterile saline.4) Clamp chest tube for 4 hours (observe patient for 10 minutes for problemswith breathing).5) Mobilize patient.6) Check HCT, PT, PTT 1 hour after infusion (if significantly changed frombaseline, consider stopping infusion)
Candidate for TPA infusion er chest tube?
Infuse TPA per chest tube q 24 hours x 3 days(check daily Chest x-ray)
48 Hours
Clot Resolved
Re eat CT Chest
Remove Tube
Clot Resolved
Re eat CT Chest
Daily Chest X-Rays
Candidate for VATS?
Yes
No
Yes
No
Yes
No Yes
Yes
No
48 Hours
Clot Resolved
VATS Contraindications1) Coagulopathy2) Hemodynamic instability3) Inability to tolerate singlelung ventilation
-
8/8/2019 Trauma Handbook 2007
27/60
27
Blunt Abdominal Trauma
Hemod namicall unstable
Physical exam
F.A.S.T. DPL
Large amountof fluid in
abdomen
Scant/no fluidin abdomen
Grosslypositive*
Microscopicallypositive for
WBC*
Microscopicallypositive for
RBC*
To OR To ORTo OR
Continuesearch for
other sourcesof hemorrhage
*Criteria for positive DPL:Grossly positive - >10cc bloodRBC - >100,000 cellsWBC - >500 cells at least 1 hour after injury
Consider DPL if unstable
-
8/8/2019 Trauma Handbook 2007
28/60
28
Blunt Abdominal Trauma
Hemodynamically stable
Physical exam
Reliable, awake, alert,no distracting injuries
Unreliable, abnormalmental status,
distracting injuries
CT scan
Nontender
Observationeriod
Remainsnontender
Discharge 1
Tender
CT scan
Normal Abnormal 2
Admit for 23hour
observation
Admit,follow
protocols
Admit,treat other
injuries
1 If any doubt, admit the patient for at least 23 hours2 May require DPL or other evaluation depending on findings
Normal
-
8/8/2019 Trauma Handbook 2007
29/60
29
Antibiotics for Penetrating Abdominal
Trauma
Penetrating abdominalinjury requiring
laparoscopy/laparotomy
Ertapenem 1 gram IVprior to skin incision
No hollow organinjury
No further antibiotics
Hollow organinjury
No further dosing
*For patients with penicillin allergy, give ciprofloxacin 400 mg IV every12 hours (2 total doses for hollow organ injury, only the preop dose
for no hollow organ injury) and metronidazole 500 mg every 6 h (4total doses for hollow organ injury, only the preop dose for no hollow
organ injury)
-
8/8/2019 Trauma Handbook 2007
30/60
30
Anterior Abdominal Stab Wounds
Hemodynamically stable,nontender abdominal exam
Yes
To ORLocal woundexploration
Violation of anterior fascia
Definitely noviolation of
anterior fascia
Equivocalviolation of
anterior fascia
To OR for laparoscopy/laparotomy
To OR for laparoscopy/laparotomy
Discharge
For the cooperative patient,consider awake laparoscopy in
Shock / Trauma
-
8/8/2019 Trauma Handbook 2007
31/60
-
8/8/2019 Trauma Handbook 2007
32/60
32
Nonoperative Management of Blunt Splenic Injury
Hemodynamic stability mandatory for nonoperative management
CT scan Pseudoaneurysm
Age 50 Age < 50Becomesunstable
ORGrade 3-5 Grade 1,2
ICU*
Largehemoperitoneum
Small, moderatehemoperitoneum
ICU*OR
Grade 1 Grade 2-5
Floor ICU*
F/U CT 24
Stable,improving
Floor
Worse
Angio-embolization
Stable Unexplainedblood loss
Consider splenectomy OR
*ICU-serial Hct q6h,
close observation
Quantitation of hemoperitoneum:Small perihepatic/splenicModerate small + paracolic gutter Large moderate + pelvis
Outpatient Management
Grade 1 2 Grade 3-5
CT if clinicallyindicated
CT in 1 monthHealed Not healed
Activity ad lib Light duty, repeat CT in 1month if indicated
-
8/8/2019 Trauma Handbook 2007
33/60
-
8/8/2019 Trauma Handbook 2007
34/60
-
8/8/2019 Trauma Handbook 2007
35/60
35
AAST Liver Injury Scale
Grade* Type of Injury Description of injuryHematoma Subcapsular, 3 Couinauds segments within a singlelobeV
Vascular Juxtahepatic venous injuries; ie, retrohepatic venacava/central major hepatic veinsVI Vascular Hepatic avulsion
*Advance one grade for multiple injuries up to grade III
-
8/8/2019 Trauma Handbook 2007
36/60
36
AAST Kidney Injury Scale
Grade* Type of Injury Description of injury
Contusion Microscopic or gross hematuria, urologic studiesnormalIHematoma Subcapsular, nonexpanding without parenchymal
lacerationHematoma Nonexpanding perirenal hematoma confirmed torenal retroperitoneumIILaceration 1.0 cm parenchymal depth of renal cortex withoutcollecting system rupture or urinary extravagation
IV Laceration Parenchymal laceration exteding through renalcortex, medulla, and collecting system
Laceration Completely shattered kidneyV
Vascular Main renal artery or vein injury with containedhemorrhage
VI Vascular Avulsion of renal hilum which devascularizeskidney
*Advance one grade for bilateral injuries up to grade III
-
8/8/2019 Trauma Handbook 2007
37/60
37
Pelvic Fracture Management
Initial assessment & A-P pelvic x-ray
Open
Exsanguinatinghemorrhage
BP~ 110
Algorithm for stable blunt
abdominaltrauma
Orthopedics
consult
-
8/8/2019 Trauma Handbook 2007
38/60
38
Tile Classification of Pelvic FracturesType A Stable fractures
A1 Fractures not involving ring; avulsion injuries
A2 Stable, minimal displacement; iliac wing, isolated ramiA3 Transverse fracture of sacrum
Type B Rotationally unstable, but vertically andposteriorly stable
B1 External rotation instability; open book injury
B2 Internal rotation instability; lateral compression injuryB3 Bilateral rotationally unstable injuryType C Rotationally, posteriorly, and vertically
unstable
C1Unilateral injury; ileal fracture, SI disruption, sacralfracture
C2 Bilateral injury; one side rotationally unstable, one sidevertically unstableC3 Bilateral injury; both sides completely unstable
-
8/8/2019 Trauma Handbook 2007
39/60
39
To Ligate or Not to Ligate
Injury Best Mode of Action
Infrarenal vena cava Repair Can ligate
Suprarenal vena cava Repair Cannot ligate - at least 50% mortality)
Internal jugular vein Repair Can ligate unilaterally
Brachiocephalic vein Repair Can ligate unilaterally
Subclavian vein and artery Repair Can ligate
Superior vena cava Repair Can ligate in life-threatening situations
Carotid artery Repair Can ligate in life-threatening situations
Mesenteric veins Ligate
Portal vein Repair
Can ligate if isolated injury, but at least 50%
mortality rate secondary to massive fluid
sequestration in splanchnic vascular bed and bowel
necrosis
Right renal vein Repair Cannot ligate - fewer collaterals than left renal vein
Popliteal vein Repair Cannot ligate
Femoral vein Repair Can ligate
Lobar bile duct Ligate
Celiac artery Ligate
Left gastric artery Ligate
Common/proper hepatic
arteries Ligate Especially if proximal to gastroduodenal branch
Right/left hepatic arteries Ligate Especially if portal vein is intact
Splenic artery Ligate Short gastric a. from left gastroepiploic
Iliac vein - comm/ext Ligate
Iliac artery - comm/ext Repair
Femoral/popliteal arteries Repair
Tibial arteries Repair Can ligate but need to ensure patency of other leg
arteries
Brachial artery Repair Can ligate if distal to profunda brachi branch since
the elbow has rich collateral blood flow
Radial/ulnar arteries Repair Can ligate but need to ensure patency of other artery
and palmar arch
-
8/8/2019 Trauma Handbook 2007
40/60
40
Neurovascular Injuries Associated with Fractures or Dislocations
Orthopedic Injury Neurovascular Injury
Anterior shoulder dislocation Axillary nerve, axillary arteryHumeral shaft fracture Radial nerveSupracondylar humeral
fractureBrachial artery
Distal radius fracturePerilunate dislocation
Median nerve
Posterior hip dislocation Sciatic nerveSupracondylar femur fracturePosterior knee dislocation
Popliteal artery
Tibial plateau fracture Popliteal artery, tibioperoneal
trunkProximal fibula fracture Peroneal nerve
-
8/8/2019 Trauma Handbook 2007
41/60
41
Fracture/dislocation of Extremity
Equal pulses,ABI .7
Pulse deficit, ABI< .7
Orthopedics consult,reduce injury
Orthopedics consult,reduce injury
Pulses still equal
Orthopedicsmanagement of
injury
Pulses equal Pulse deficit
Angiogram inoperating
room
-
8/8/2019 Trauma Handbook 2007
42/60
42
Chart of Muscle Groups and Nerve and Nerve Root Supply
Muscle Nerve Root Nerve
Cervical flexors C1 C4
Cervical extensors C1 C4
Trapezius Cranial nerve XI
Sternocleidomastoid Cranial nerve XI
Arm abduction
0 15 o , supraspinatus
15 to 90 o , deltoid
>90 o , trapezius & serratus
anterior
C4 C6
C5 C6
C5 C7
Suprascapular
Axillary
Long thoracic
Biceps C5 C6 Musculocutaneous
Forearm supination C5 C6 MusculocutaneousForearm pronation C6 C7 Median
Wrist flexors C7 C8, T1 Median
Wrist extensors C6 C8 Radial
Hand intrinsics C7 T1 Median and Ulnar
Hip flexion L1 L3 Femoral
Hip extension L4 S1 Sciatic
Thigh abduction L4 S2 Superior gluteal
Thigh adduction L2 L4 Obturator
Leg flexion L4 S2 Sciatic
Leg extension L2 L4 Femoral
Foot plantar flexion L5 S1Superficial peroneal and
tibial
Foot dorsiflexion L4 L5 Deep peroneal
Great toe extension L4 L5, S1 Deep peroneal
Foot inversion L4 L5 Deep peroneal
Foot eversion L5 S1 Superficial peroneal
Rectal spinchters S2 S4 Pudenal
-
8/8/2019 Trauma Handbook 2007
43/60
43
Mangled Extremity Severity Score
Skeletal / soft-tissue injury Low energy (stab; simple fracture; pistol gunshot wound) 1
Medium energy (open or multiple fractures, dislocation) 2
High energy (high speed RTA or rifle GSW) 3
Very high energy (high speed trauma + gross contamination) 4
Limb ischemiaPulse reduced or absent but perfusion normal 1*
Pulseless, paresthesias, diminished capillary refill 2*
Cool, paralyzed, insensate, numb 3*
Shock Systolic BP always > 90 mm 0
Transient hypotension 1
Persistent hypotension 2
Age (years)< 30 0
30-50 1
> 50 2
* Score doubled for ischemia > 6 hours
The MESS is the sum of scores from each category. Scores < 7 are associated with limbsalvage, Scores > 10 are associated with primary amputation. Outcome is variable for scores 7-10.
-
8/8/2019 Trauma Handbook 2007
44/60
44
Diagnosis of Ventilator Associated Pneumonia
Indications for bronchoscopy with bronchoalveolar lavage (FOB + BAL)
- Patient must have at least three of the following:
1. Fever (temperature > 100.5) or hypothermia (T < 96)2. Abnormal WBC (>10,000, 10% bands)
3. Purulent sputum
4. New or changing infiltrate on chest x-ray
BRONCHOSCOPY + BAL T ECHNIQUE
1. Routine suctioning with in-line catheter of the upper airway until clear.
2. Increase FiO 2 to 100%, change IMV rate if necessary.
3. Sedate patient as necessary. Pharmacologic paralysis is NOT necessary.
4. Advance bronchoscope into affected lung segment (as seen on CXR) or
LLL (if bilateral infiltrates). DO NOT USE SUCTION OR CONNECT
SUCTION LINE TO BRONCHOSCOPE.
5. Scope should be advanced to the smallest bronchial segment possible to
perform BAL.6. Use 100cc sterile nonbacteriostatic saline in 20cc aliquots. Inject 20cc
then immediately aspirate and pool the effluent for quantitative cultures.
7. Follow up with chest radiograph.
8. Proceed to VAP Pathway for treatment.
-
8/8/2019 Trauma Handbook 2007
45/60
45
Clinical Suspicion of VAP
Fiberoptic Bronchoscopy with BAL
7 days in ICU
Vancomycin 20mg/kg IV q12h * + Cefepime 2g IV q8h *
Empiric antibiotic therapy based on timing of ICU admission
No growth to date Insignificant(1-99,999 cfu/mL)
Significant( 100,000)
Streamline antibiotictherapy**
Discontinue antibiotictherapy**
Continue empiricantibiotic therapy
100,000 cfu/mL
Definitive antibiotic therapy(see Definitive Therapy Pathway for TICU )
Defined as the appearance of a new or changing infiltrate on chest radiograph and at least 2 of he following:Abnormal temperature (>38 oC or 10,000 cells/mm 3 or 10%mmature bands);Macroscopically purulent sputumIf severe beta-lactam allergy, change: Unasyn to Levofloxacin 750 mg IV Q24H, Cefepime to
Ciprofloxacin 400 mg IV Q8H; dosage adjustment may be necessary based on renal function
**Continue to monitor for changes in Final culture results
Final culture results
Preliminary culture results >24 hours
Trauma ICU Ventilator-Associated Pneumonia Clinical PathwayDiagnosis and Empiric Management
-
8/8/2019 Trauma Handbook 2007
46/60
46
* Adequate antibiotic therapy is antibiotic therapy with in vitro activity against thepathogen. Patients extubated or not eligible for repeat BAL should be treated for 7 fulldays (consider 10-14 days if Pseudomonas or not responding clinically)** Consider treatment for 10,000 cfu/mL in severely injured patients with Pseudomonasand/or Acinetobacter
Use final culture result. Continue antimicrobial therapy in patients with septic shock Pseudomonas requires a follow-up BAL regardless of being early or late VAP
Trauma ICU Ventilator-Associated Pneumonia Clinical PathwayDefinitive Therapy
VAP pathogen(s)
-
8/8/2019 Trauma Handbook 2007
47/60
47
Guideline for the Prevention of Venous Thromboembolism in Critically ill Patients Approved by Pharmacy and Therapeutics Committee May 2004
Evidence-based references Geerts WH, et al. Chest 2001; 119: 132S-175S.
Available at http://www.chestjournal.org/cgi/reprint/119/1_suppl/132S(accessed 5/14/04)
Rogers FB, et al. J Trauma 2002; 53(1):142-164. Also available at http://www.east.org/tpg/dvt.pdf (accessed 5/14/04)
Modified 5/14/04
No
Sequential compressiondevices (preferred) or A-V footpumps. Consider serial duplexultrasound in high-risk patients
N
[A] Consider Inferior Vena Cava (IVC) filter in:
High-risk trauma patients with significant bleeding risk or Patients with injury pattern rendering them immobile for prolonged period of time:
a) Severe Traumatic brain injuryb) Spinal cord injury with para- or quadriplegiac) Complex pelvic fracture with associated long bonefracture(s)d) Multiple long bone fractures
Unfractionated heparin 5,000 units sq every 8 hours plusSequential compression devices (preferred) or A-V foot
pumps
Enoxaparin 30mg sq every 12 hours plusSequential compression devices (preferred) or A-V foot
pumps
Unfractionated heparin 5,000units sq every 8 hours plus
Sequential compressiondevices (preferred) or A-V foot
Enoxaparin 30mg sq every 12 hours plus
Sequential compression devices(preferred) or A-V foot pumps
Yes
Operativeacetabulum
fracture?
> 24 h post-operativePre-operative
Yes
4
Contraindication to heparin pharmacotherapy? [A]examples include: Active hemorrhage
Recent hemorrhagic stroke INR > 1.6 PTT > 60 sec Platelet count < 50 x 10 9 cells/L
Traumatic brain injury with progression on headCT >24h post-injury (consult neurosurgery)
Hx of Heparin-induced Thrombocytopenia (HIT) Epidural catheter present (consult anesthesia)
2
Primary risk factor present? [A] Spinal cord injury Spinal column fractures Long bone fracture Pelvic fracture Sacral fracture
Acetabulum fracture Traumatic brain injury Laparotomy Age > 40 plus major surgery, cancer, history of VTE, or hypercoagulable state
3
No
Yes
Reevaluate all patients for continuation of venous thromboembolism prophylaxis upon ICU discharge
Baseline CBC, BMP, PTT, and PT/INR
*Note: May not be indicated in
burn patients unless other risk factors are present.
*
1
-
8/8/2019 Trauma Handbook 2007
48/60
48
Natural Products with Potential to Act as Blood Modifiers
Natural Products THOUGHT to have Blood Modifying EffectsHerb(other names)
Effect Ingredient(s)Responsible
Comments
Angelica root ( Angelicaarchangelica , root of theHoly Ghost)
AnticoagulantAntiplatelet
Coumarinconsitiuents
There is some evidence that therelated Angelica species can inhibitplatelet aggregation and lower prothrombin time when combinedwith warfarin.
The coumarin constituents of relatedAngelica species can inhibit humanplatelet aggregation in vitro. Therelated species, Angelica sinensis,can lower prothrombin time in rabbitswhen coadministered with warfarin.
Anise (Pimpinella anisum ,aniseed, sweet cumin)
Anticoagulant Coumarin constituents Anticoagulant effects have been seenwith excessive doses of anise. (Typicaldose is 0.5-1 gram of the dried leaf or 50-200 mL of the essential oil.)
Theoretically, excessive use of anisemight prolong coagulation, increasingPT/INR and test results, due tocoumarins contained in anise.
Asafoetida (Ferula assa-foetida , assant, devilsdung, fum, giant fennel)
Anticoagulant Coumarin constituents Anticoagulant effects have been notedin vivo.
Dong Quai ( Angelicasinensis , Chinese angelica,Danggui)
AnticoagulantAntiplatelet
Coumarin constituents Dong quai can potentiate the therapeuticand adverse effects of warfarin andantiplatelet drugs.
Fish Oils (omega-3 fattyacids)
Antiplatelet Docosahexaenoic acid(DHA)
Eicosapentaenoic acid(EPA)
The antithrombin activity of fish oil is dueto prostacyclin synthesis, vasodilation,reduced platelet counts andadhesiveness, and prolonged bleedingtime.
Fucus (Fucus vesiculosis ,bladderwrack, kelp, blacktang, cutweed)
Anticoagulant Fucoidin The isolated fraction, fucoidin, has 40-50% of the blood anticoagulant activityof heparin, and fucus can increase therisk of bleeding.
-
8/8/2019 Trauma Handbook 2007
49/60
49
Natural Products with THEORETICAL Potential to Have Blood Modifying EffectsHerb (Other names) Effect Ingredient(s)
Responsible Comments
Agrimony ( Agrimoniaeupatoria , agromonia,cocklebur)
Coagulant Vitamin K constituent Excessive doses of agrimony couldinterfere with anticoagulant therapy.(Typical dose is 3 grams/day.)
Arnica montana , leopardsbane, wolfs bane, mountaintobacco)
Anticoagulant Coumarin constituents Arnica could potentiate the effects of anticoagulant and antiplatelet drugs.
Aspen (Populi cortex, Populi
folium )
Antiplatelet Salicin Salicin is a salicylate constituent.
However, in vitro studies providepreliminary data that suggest salicinmight not potentiate the effects of anticoagulant drugs.
Black cohosh (Cimicifugaracemosa , baneberry, blacksnakeroot, bugwort)
Antiplatelet Salicylate There is insufficient reliable informationto determine if there is enough salicylatepresent in black cohosh to havesignificant effects.
Bogbean (Menyanthestrifoliata , buckbean, marshtrefoil, water shamrock)
Bleeding risk Unidentifiedconstituent
Excessive doses of bogbean canincrease the risk of bleeding due to thehemolytic effects of an unknownconstituent. (Typical dose is 1-2 mL of the 1:1 liquid extract in 25% alcohol TIDor 1-3 grams of the dried leaf TID.)
Boldo (Peumus boldus ,
boldine)
Anticoagulant Coumarin constituents Excessive doses could increase the risk
of bleeding. (Typical dose is 60-200 mgof the dried leaf TID.)
Borage Seed Oil (Boragoofficinalis , burage,starflower)
Anticoagulant
Antiplatelet
Gamma linolenic acid Borage seed oil could prolong bleedingtime.
Bromelain ( Ananascomosus , bromelin)
Antiplatelet Enzyme constituent Bromelain could increase the risk of bleeding when used in combination withantiplatelets or anticoagulants.
Capsicum (Capsicumfrutescen , African pepper,cayenne, chili pepper)
Antiplatelet Capsaicinoidconstituents
Capsicum has led to increasedfibrinolytic activity and could prolongbleeding time.
Celery ( Apium graveolens ,smallage, Apii fructus)
Antiplatelet Apiogenin (coumarin) Celery could have anticoagulant effectsdue to the apiogenin constituent.
Clove (Syzygium
aromaticum , caryophyllus)
Antiplatelet Eugenol Clove contains a volatile oil that consists
primarily of eugenol.Danshen (Salviamiltiorrhiza , red sage, salviaroot)
Anticoagulant Protocatechualdehyde
3,4-dihydroxyphenyl-lactic acid
There is one case report of increasedinternational normalization ratio (INR)with concomitant use of danshen andwarfarin.
European Mistletoe(Viscum album , all-heal,devils fuge, drudenfuss)
Coagulant Lectin Studies show that lectin can haveagglutinating activity and could interferewith anticoagulant or coagulant therapy.
Fenugreek (Trigonellafoenum-graecum , birds foot,Greek hay)
Anticoagulant Coumarin constituents Fenugreek could potentiate the effects of anticoagulant and antiplatelet drugs.
Feverfew (Tanacetum parthenium , featherfew,midsummer daisy,
bachelors button)
Antiplatelet Crude extracts The crude extracts can inhibit plateletaggregation and the neutrophil andplatelet secretory activity. This could
potentiate the effects of anticoagulantand antiplatelet drugs.Ginseng, Panax (Asianginseng, Korean red,
jintsam)
AnticoagulantAntiplatelet
Active constituents Panax ginseng could decrease theeffectiveness of warfarin and affectclotting time.
Goldenseal (Hydrastiscanadensis , yellow puccoon,eye balm)
Coagulant Berberine Goldenseal could inhibit theanticoagulant effects of heparin.
Horse Chestnut ( Aesculushippocastanum , escine,venostat)
Anticoagulant Aesculin (coumarin) Aesculin may increase bleeding time dueto antithrombin activity, which couldincrease the risk of bleeding when usedconcomitantly with anticoagulants or antiplatelets.
-
8/8/2019 Trauma Handbook 2007
50/60
-
8/8/2019 Trauma Handbook 2007
51/60
51
odorata , coumarouna,torquin bean)
coumarin and theoretically potentiate therisk of bleeding associated withanticoagulant drugs or natural products.
Turmeric (Curcuma longa ,tumeric, Indian saffron)
Antiplatelet Curcumin Curcumin has anti-inflammatory activityand could potentiate the antiplateletactivity of other drugs or naturalproducts.
Wild Carrot (Daucus carota ,Queen Annes lace,beesnest plant)
Anticoagulant Coumarin constituents Large amounts of wild carrot couldpotentiate the risk of bleeding withanticoagulant drugs or natural products.
Wild Lettuce (Lactuca
virosa , green endive, lettuceopium)
Anticoagulant Coumarin constituents Large amounts of wild lettuce could
potentiate the risk of bleeding withanticoagulant drugs or natural products.
Willow Bark (Salix alba ,white willow, silberweide)
Antiplatelet Salicylate constituents Data suggests irreversible inhibition of thrombocytes is unlikely and there mightbe no increase interaction with bloodcoagulants.
Yarrow ( Achillea millefolium ,thousand-leaf, wound wort)
Coagulant Achilleine There is some evidence to suggest thatachilleine has decreased clotting time.
HERBS WITH ANTICOAGULANT/ANTIPLATELET POTENTIAL : Concomitant use of herbs that have coumarin constituents or affectplatelet aggregation could theoretically increase the risk of bleeding in some people. These herbs include anise, arnica, asafoetida,bogbean, boldo, capsicum, celery, chamomile, clove, danshen, fenugreek, feverfew, garlic, ginger, ginkgo, Panax ginseng, horsechestnut, horseradish, licorice, meadowsweet, prickly ash, onion, papain, passionflower, poplar, quassia, red clover, turmeric, wildcarrot, wild lettuce, willow, and others.
-
8/8/2019 Trauma Handbook 2007
52/60
52
Weaning from Mechanical Ventilation
Daily screening
Problem for which patient wasintubated is controlled
No
Continuemechanicalventilation
Yes
SaO 2 90%FiO 2 0.5PEEP 5 cm H 2O
Airway reflexes intactNo vasopressors or significant sedation
Yes
No
Therapist to measure RR/Vt
No RR/Vt < 105 breaths/min/L
Spontaneous breathing trial
RR > 35 breaths/min for more than 5 minutesSaO 2 < 90%
Yes
No
Extubate
-
8/8/2019 Trauma Handbook 2007
53/60
53
MANAGEMENT OF HYPERTENSIONDiagnosis of Hypertensive CrisisImmediate control to minimize end organ damage (CNS - hypertensive encephalopathy; cardiac- AMI, BAI, dissecting aortic aneurysm; renal ARF) is necessary.Otherwise BP should be lowered slowly and cautiously.
Management of HypertensionThere are many causes of hypertension in ICU patients, common causes include:
- underlying hypertension- agitation- pain- withdrawal
- cold, shivering- hypoxia, hypercarbia- increased ICP- transducer height etc.
Treat underlying causes prior to administration of antihypertensives
Common intravenous antihypertensive agents:
Drug Action Effect Dose Comments
Metoprolol-1 antagonist(min -2 antagonist)
Negative chronotropyNegative inotropy
IVP: 2.5 to 15 mg slow IVP every 6hours
Half-life 4 to 6 hoursOral:IV conversion 2.5:1No vasodilation
Labetalol-1 antagonist(mod -2 antagonist) -1 antagonist
Negative chronotropyNegative inotropyVasodilation
IVP: 5 to 20 mg slow IVP every 1 to4 hoursBolus: 5-20 mg IVPInfusion: 0.5 to 4 mg/min (Titrate)
Half-life 4 to 6 hoursMonitor closely inasthmatic patient (beta-2 antagonist)
Esmolol-1 antagonist(min -2 antagonist)
Negative chronotropyNegative inotropy
Bolus: 250-500 mcg/kg slow IVPInfusion: 25-100 mcg/kg/min(Titrate)
Half-life ~ 15 minNo vasodilation
Nitroglycerin Exogenous source of nitric oxideVenous vasodilation(min arterial dilation)
Infusion: 5 to 20 mcg/min (Titrate;max 400 mcg/min)
MethemoglobinemiaHeadache
Nitroprusside Exogenous source of
nitric oxide
Arterial and venous
vasodilation
Infusion: 0.1 to 10 mcg/kg/min
(Start low and Titrate)
Profound hypotensionCyanide toxicityReflex tachycardia
Hydralazine Direct arterial smoothmuscle relaxation Arterial dilationIVP: 5 to 20 mg slow IVP every 4to 6 hours
Intrapatient variabilityReflex tachycardia
Enalapril ACE Inhibition Vasodilation(arterial > venous)IVP: 0.625 to 1.25 slow IVP every6 hours
HyperkalemiaAcute renal failureAngioedema
Oral antihypertensives can be used in patients with stable hemodynamics. Otherwise use of IVantihypertensives is more easily titratable in ICU patients.Note on choice of antihypertensives: avoid -blockers in patients with increased adrenergic activity (pheochromocytoma, use of sympathomimetic drugs such as cocaine, amphetamine etc) avoid -blockers in patients with poor LV function, also check for other contraindications(bronchospasm) nimodipine produces cerebral vasodilation, effect noticeable in areas of brain with restrictedcirculation than healthy areas, usually used in patients with vasopasm after subarachnoidhemorrhage nitrates and nitroprusside can produce cerebral vasodilation and hence should be avoided inpatients with intracranial pathology prolonged nitroprusside administration can lead to acidosis and cyanide toxicity
-
8/8/2019 Trauma Handbook 2007
54/60
57
1Mechanically ventilated trauma
patient requiring sedation
2Patient w/TBI,
ICP, or requiringfrequent
neurologicexaminations?
6Pt expected to
require sedationfor 24 hours?
9Preferred Midazolam prnagitation 3 PLUS Morphinesulfate prn pain/agitation 2
Alternative - Propofol (generic)continuous infusion 1 PLUS
Morphine sulfate prnpain/agitation 2
Titrate to Riker SAS of 4
10Continued need
for sedation past24 hours?
12D/C Sedation Protocol, continue Morphine
sulfate prn pain (or morphine sulfatecontinuous infusion) 2
7Lorazepam prn agitation, THEN
Lorazepam continuous infusion if dosingrequirements are high 4
PLUSMorphine sulfate prn pain/agitation, THEN
Morphine sulfate continuous infusion if dosingrequirements are high 2
Titrate to Riker SAS of 4In refractory cases, may use
Propofol (generic) continuous infusion 1 PLUSMorphine sulfate prn pain/agitation 2
3Preferred - Propofol (Diprivan brand) continuous
infusion 1 PLUS Morphine sulfate prnpain/agitation 2 OR
Alternative - Fentanyl continuous infusion 2 Titrate to Riker SAS of 4
May consider use of neuromuscular blocker to
assist with ventilator compliance
4Patient w/TBI, ICP,
or requiringfrequent neurologic
examinations?
5Go to 12
8Pt requiring
sedation after 24 hours?
11Go to
12
YES
YES
YES
REASSESSPt every
shift & asneeded
REASSESSPt every
shift & asneeded
REASSESSPt every
shift & asneeded
NO
NO
NO
NO
NO
YES
YE
-
8/8/2019 Trauma Handbook 2007
55/60
54
ICU Pharmacologic AgentsATRACURIUM Half life: 20 minutes. Cleared in plasma via Hoffman reaction; therefore, suitable for
usage in renal failure. Titrate to 2/4 TOF. Dosage (continuous infusion): 0.1 mg/kg/h. Cost: $11.46/100 mg.
24-hour cost (70 kg patient): ~$19.00/day.
PANCURONIUM Half-life: 2 hours. May cause tachycardia. Titrate to 2/4 TOF. Dosage (continuous
infusion): 0.06-0.1 mg/kg/h. Cost: $1.79/10 mg. 24-hour cost: ~$28.00/day.
VECURONIUM Half-life: 1.5 hours. Clearance adversely affected by renal failure. Titrate to 2/4 TOF.
Dosage (continuous infusion): 0.01 mg/kg/h. Cost: $12.39/10 mg. 24-hour cost: ~$20.00/day.
MIDAZOLAM Short acting benzodiazepine. Duration of action: 2 hours. Excellent amnestic effect. Use
with caution in elderly; may cause hypotension/respiratory depression. Contraindicated in hepatic failure.
Dosage (continuous infusion): 2 mg/h. Cost: $9.48/5 mg. 24-hour cost: ~$90.00/day.
LORAZEPAM Intermediate acting benzodiazepine. Duration of action: 8-20 hours. May cause
paradoxical reactions in the elderly. Prolonged use can lead to prolonged sedation. Dosage (continuousinfusion): 1 mg/h. Cost: $15.89/40 mg. 24-hour cost: ~$8.00/day.
HALOPERIDOL Butyrophenone/antipsychotic. Does not cause sedation per se; does not cause
respiratory or cardiovascular depression. Mechanism of action is to cause affective dissociation. Does hav
limited anticholinergic effects; may cause dystonia/tardive dyskinesia. Should use Cogentin at regularly
scheduled intervals. Half-life: 18 hours. Dosage: 5-10 mg/dose. Titrate to affect up to 50 mg/dose. Cost:
$0.57/5 mg. Cost per dose: $0.57-5.70.
MORPHINE Opiate, the gold standard analgesic in the ICU setting. Has sedative as well as analgesic
properties. Metabolites accumulate in renal failure. Duration of action: 4-5 hours. Causes respiratorydepression, histamine release, and hypotension. Dosage (continuous infusion): 2-4 mg/h. Cost: $5.76/100
mg. 24-hour cost: $3.00-6.00/day.
FENTANYL Short acting opiate. Duration of action: 1-2 hours. Sedative and analgesic effects. Causes
respiratory depression. Does not have histamine release. Much more stable than morphine from
cardiovascular standpoint. Dosage (continuous infusion): 1-5 mcg/kg/min. Cost: $1.28/1000 mcg. 24-hour
cost: $12.80-64.00/day.
PROPOFOL Lipid soluble, ultra-short-acting anesthetic. Prepared in lipid carrier. Duration of action: 15
minutes. Easily titratable. Lowers ICP. Should not be used in patients with hypertriglyceridemia. Exhibits
three-compartment redistribution with prolonged use, leading to prolongation of action. Bolus doses may
cause hypotension. Rare fatal reactions noted in children. Dosage (continuous infusion): 20-200
mcg/kg/min. Cost: $49.95/1000 mg. 24-hour cost: $100.00-1,000.00/day. ALL PATIENTS RECEIVING
DIPRIVAN MUST HAVE DAILY SERUM LACTATE AND CPK CHECKED. IF EITHER RISES, STOP
DIPRIVAN IMMEDIATELTY.
-
8/8/2019 Trauma Handbook 2007
56/60
55
Alcohol Withdrawal Protocol
Patient with riskfactors for alcohol
withdrawalsyndrome
Obtain:
1. liver function panel, INR/PT
2. BMP, magnesium, phosphorus, albumin3. Blood glucose monitoringProvide:
1. Thiamine 100mg once daily IV/IM/PO2. Folic acid 1mg once daily PO/IV3. Multivitamin once daily or Cernevit 5ml inminimum 500ml IVF once daily4. Adequate hydration
High clinicalsuspicion for
withdrawal
Activewithdrawal
Lorazepam 2-4mg PO/IV/IMq 6 hrs x 4 doses, then 1-2mg PO/IV/IM q 6 hrs 2 8doses (3 day prophylaxiswean). Monitor vital signs
and status q 4-6 hrs.
Ethanol 5% in D5W atinitial rate of 50 ml/hr.
Titrate for symptoms of early withdrawal. Wean
over 3 days. Monitor vitalsigns and status q 4-6 hrs.
Transfer tomonitored
unit
Lorazepam 2-4mg IVevery 1 hr until lightly
sedated andsymptoms resolved.
Monitor vital signs andstatus every hour
Select desired therapy:Lorazepam (preferred) or ethanol
dripNote:ethanol is contraindicated in patientswith pancreatitis and liver disease
-
8/8/2019 Trauma Handbook 2007
57/60
-
8/8/2019 Trauma Handbook 2007
58/60
58
Stress Ulcer ProphylaxisPatient Admitted toMICU/SICU/TICU
Evidence of activeGI bleed
MAJOR RISK FACTORS Severe Head TraumaBurns > 30% BSAPrior Organ TransplantRenal FailureRecent PUD (6 weeks)*Hypotension/Shock
> 48h Mech. VentilationOR
Coagulopathy
IV PROTON PUMP INHIBITORi.e. Pantoprazole 40 mg IV every
24 hours
IV H2 BLOCKERi.e.Ranitidine 50 mg IV every 8 hours
(For Cr Cl < 50) 50 mg IV daily
ORAL H2 BLOCKERi.e. Ranitidine 150mg PO BID
(For Cr Cl < 50) 75 mg PO BID
OROral Proton Pump Inhibitor
i.e. Pantoprazole 40 mg every24 hours
Treat active bleeding
References1. Cook DJ , Fuller HD, Guyatt GH et al.Risk factors for gastrointestinal bleeding in critically ill patients.N Engl J Med. 1994 Feb
10;330(6):377-81.2. Levy MJ, Seelig CB, Robinson NJ et al.Comparison of omeprazole and ranitidine for stress ulcer prophylaxis.Dig Dis Sci
1997Jun;42(6):1255-93. CookD, HeylandD,Griffith L,et al:Risk factors for clinically important UGIB in patients requiring mechanical ventilation. Crit
Care Med 1999;27:281228174. Jung R, MacLaren R. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients. Ann Pharmacother. 2002
Dec;36(12):1929-37*Endosco ic or radio ra hic evidence of e tic ulcer disease in recedin 6 weeks
No
No Prophylaxis IndicatedRe-evaluate need for
treatment
NoOn Transfer/Discharge
ORRisk Factors Resolved
Discontinue Therapy
No
Yes
This clinical practice guideline is a systematically developed algorithm intended to assist practitioner and patient decisionsabout appropriate health care for specific clinical circumstances. This guideline is not a fixed protocol that must be followed,but is intended for health care professionals and providers to consider. While it identifies and describes generallyrecommended courses of intervention, it is not presented as a substitute for the advice of a physician or other knowledgeablehealth care professional or provider. Individual patients may require different treatments from those specified in this particular guideline.
No
Yes
Yes
Yes
Tolerating TubeFeedings or PO
Patient with SRMD,PUD, or GERD*
*SRMD=Stress Related Mucosal DamagePUD=Peptic Ulcer DiseaseGERD=Gastroesophageal Reflux
-
8/8/2019 Trauma Handbook 2007
59/60
59
General Management Principles for Severe (GCS 3-8) andModerate (GCS 9-12) TBI
Use very short-acting sedatives if needed, for frequent neurological exams Especially important in first 24 hours
Sedation holiday for nursing neuro check unless otherwise ordered Convert field collar to Miami J until ligamentous injury can later be ruled out Insertion of intraparenchymal ICP monitor after coagulopathy (if present)
corrected (Normal PTT and INR < 1.2 desireable, 20 mm Hg x > 5 minutes): Notify NeurosurgeryFirst Tier Therapies: Ensure HOB elevated Ensure no compression from cervical collar and neck in neutral position Ensure ventriculostomy (if present) patent and functioning Sedation and analgesia with Diprivan Drip (discontinue if elevation of CPK or
lactate) or Fentanyl or Morphine Drip or Intermittent Dosage Maintain Hyperosmolar Euvolemia
A Catheter, Mannitol +/- Lasix, hypertonic saline boluses, serum Na andosmolarity every 6 hours
No hyperosmolar agents if osmolarity > 320 Goal serum Na 145-155 usually
Cerebral Perfusion Pressure Goals 50-70 mm Hg usually Neosynephrine preferred pressor if pressors needed Dopamine in low doses
-
8/8/2019 Trauma Handbook 2007
60/60